Representative before the EPO

Employment test 51 - 200 employees
Company dna vossius and partner
operating since 1961
Headquarter in Munich and 3 offices
active in Legal Services and IP-related Communication Service

Dirk Harmsen has worked on the following 5 EPO patent applications which have been published in the last five years:

EP11830770

BENZO[K]FLUORANTHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT CONTAINING SAME

IPC classification:
C07D 213/22, C07D 401/04, C07D 471/04, C09K 11/06, H01L 51/50
Applicant:
Idemitsu Kosan Co Ltd
Agent:
Dirk Harmsen, Vossius & Partner Patentanwälte Rechtsanwälte mbB
Status:
EXAMINATION IN PROGRESS
EP11713376

ESTER COMPOUND AND USE THEREOF

IPC classification:
A01N 53/00, A01P 7/04, C07C 323/60
Applicant:
Sumitomo Chemical Company Limited
Agent:
Dirk Harmsen, Vossius & Partner Patentanwälte Rechtsanwälte mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP10836029

FUSED HETEROCYCLIC COMPOUND HAVING AMINO GROUP

IPC classification:
A61K 31/5365, A61K 31/5415, A61K 31/542, A61P 25/28, A61P 43/00, C07D 265/18, C07D 279/08, C07D 417/12, C07D 498/04, C07D 513/04
Agent:
Dirk Harmsen, Vossius & Partner Patentanwälte Rechtsanwälte mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP10833290

ANTITHROMBOTIC AGENT

IPC classification:
A61K 31/185, A61P 7/02, A61P 9/00, A61P 9/10, A61P 11/00, A61P 25/00
Applicant:
Taiho Pharmaceutical Co., Ltd.
Applicant:
Tokai University Educational System
Agent:
Dirk Harmsen, Vossius & Partner Patentanwälte Rechtsanwälte mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP10833248

INDOLE COMPOUND AND PHARMACEUTICAL USE THEREOF

IPC classification:
A61K 31/416, A61K 31/4178, A61K 31/422, A61K 31/427, A61K 31/433, A61K 31/437, A61K 31/4439, A61K 31/454, A61K 31/496, A61K 31/5377, A61K 31/55, A61P 29/00, A61P 37/02, A61P 37/06, A61P 37/08, A61P 43/00, C07D 401/14, C07D 403/04, C07D 403/14, C07D 405/14
Applicant:
Japan Tobacco, Inc.
Agent:
Dirk Harmsen, Vossius & Partner Patentanwälte Rechtsanwälte mbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature